Viewing StudyNCT05108740



Ignite Creation Date: 2024-05-06 @ 4:50 PM
Last Modification Date: 2024-10-26 @ 2:17 PM
Study NCT ID: NCT05108740
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2021-12-09
First Post: 2021-09-09

Brief Title: MAP Treatment Plan With Afinitor for Postmenopausal Women With Advanced HR Breast Cancer
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Advanced Hormone Receptor Positive HR Breast Cancer
Keywords:
Name View
everolimus View
Breast Cancer View
MAP View
Hormone receptor positive View
Afinitor View